Abstract
P. vivax challenges Malaria control, surpasses P. falciparum distribution and subjects 2,5 billion people to the risk of being infected. Naturally acquired immunity, observed on individuals exposed to several Malaria episodes, does not prevents infection but limits parasitaemia, preventing it´s escalation and the manifestation of symptoms. Clinical immunity to Malaria in P. falciparum end…